Eiger BioPharma: Q4 Earnings Snapshot

PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — Eiger BioPharmaceuticals Inc. (EIGR) on Thursday reported a loss of $25.1 million in its fourth quarter.

On a per-share basis, the Palo Alto, California-based company said it had a loss of 57 cents.

The biopharmaceutical company posted revenue of $2.7 million in the period.

For the year, the company reported that its loss widened to $96.8 million, or $2.32 per share. Revenue was reported as $13.5 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EIGR at https://www.zacks.com/ap/EIGR

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up